Tiotropium HandiHaler in the treatment of COPD: a safety review.

International journal of chronic obstructive pulmonary disease

Volumn 4, Issue , 2009, Pages 397-409

  Kesten, Steven ^a   Celli, Bart ^a   Decramer, Marc ^a   Leimer, Inge ^a   Tashkin, Donald ^a  

^a BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; SCOPOLAMINE DERIVATIVE; TIOTROPIUM BROMIDE;

AGED; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DRUG TOXICITY; FEMALE; HUMAN; MALE; MIDDLE AGED; NEBULIZER; REVIEW; TREATMENT OUTCOME;

AGED; CHOLINERGIC ANTAGONISTS; CLINICAL TRIALS AS TOPIC; DRUG TOXICITY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SCOPOLAMINE DERIVATIVES; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 77949521508     PISSN: None     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/copd.s4802     Document Type: Review

References (48)